LILRB2 and peripheral arterial disease: Based on this integrated approach, we discovered the inhibitory monocyte/macrophage-expressed receptor—leukocyte immunoglobulin-like receptor B2 (LILRB2, LIR-2, ILT-4; ENSG00000131042, human chromosomal region 19q13.4)—to be strongly associated with the PAD phenotype.